Skip to content

SOLVAY CHEMICALS INTERNATIONAL

Active Risk: not assessed
Public limited companyfounded 196957 yrs activeRansbeekstraat 310, 1120 Brussel, BelgiumKBO/BCE: BE 0406.804.736
Summary

SOLVAY CHEMICALS INTERNATIONAL is a financial institution; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2025 annual accounts show equity of €89.18M and a net result of €-12.67M. Equity is shrinking by ~8.7% per year across the filed fiscal years. Its solvency ranks better than 48% of 2399 sector peers (fiscal year 2025). The company has been active since 1969 and the Belgian State Gazette contains no insolvency or warning signals.

SOLVAY CHEMICALS INTERNATIONALActive

Checked score

Outside the general model
Model not applicable to financial institutions
The health score weighs liquidity, leverage and margins against norms for trading and manufacturing companies. A bank, insurer or financial holding has a fundamentally different balance-sheet structure, so those ratios, and hence the score, carry no meaning here. That is why we show no financial axes either.
Credit check for your own amount and term

Signals

1 signal. The signal on the left, the evidence on the right.
○neutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 10-06-2026, 51 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
51 d early
2024
42 d early
2023
34 d early
2022
42 d early
2021
38 d early
2020
51 d early
2019
39 d early
← before the deadline after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
25-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, full schema

Equity
€89.18M▼ 43.1%
2024 · €156.82M
2018: €263.75Mhighest in 8 years 2019: €190.82M▼ -27.6% vs 2018 2020: €197.17M▲ +3.3% vs 2019 2021: €171.79M▼ -12.9% vs 2020 2022: €238.76M▲ +39.0% vs 2021 2023: €163.38M▼ -31.6% vs 2022 2024: €156.82M▼ -4.0% vs 2023 2025: €89.18M▼ -43.1% vs 2024lowest in 8 years
2018 → 2025
Net result
€-12.67M
2024 · €17.44M
2018: €10.84M 2019: €34.67M▲ +220% vs 2018 2020: €6.35M▼ -81.7% vs 2019 2021: €-25.38M▼ -500% vs 2020lowest in 8 years 2022: €66.97M▲ +364% vs 2021highest in 8 years 2023: €-5.38M▼ -108% vs 2022 2024: €17.44M▲ +424% vs 2023 2025: €-12.67M▼ -173% vs 2024
2018 → 2025
Total assets
€151.61M▼ 45.4%
2024 · €277.66M
2018: €328.44M 2019: €251.00M▼ -23.6% vs 2018 2020: €253.95M▲ +1.2% vs 2019 2021: €243.88M▼ -4.0% vs 2020 2022: €346.53M▲ +42.1% vs 2021highest in 8 years 2023: €312.08M▼ -9.9% vs 2022 2024: €277.66M▼ -11.0% vs 2023 2025: €151.61M▼ -45.4% vs 2024lowest in 8 years
2018 → 2025
Solvency
58.8%▲ 2.3pp
2024 · 56.5%
2018: 80.3%highest in 8 years 2019: 76.0%▼ -5.3% vs 2018 2020: 77.6%▲ +2.1% vs 2019 2021: 70.4%▼ -9.3% vs 2020 2022: 68.9%▼ -2.2% vs 2021 2023: 52.4%▼ -24.0% vs 2022lowest in 8 years 2024: 56.5%▲ +7.9% vs 2023 2025: 58.8%▲ +4.1% vs 2024
2018 → 2025
Trend over the years
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20212022202320242025Trend
Turnover€1.11B-€1.70B▲ 53.6%€1.47B▼ 13.7%€1.47B=€1.31B▼ 10.6% 2021: €1.11Blowest in 5 years 2022: €1.70B▲ +53.6% vs 2021highest in 5 years 2023: €1.47B▼ -13.7% vs 2022 2024: €1.47B● +0.0% vs 2023 2025: €1.31B▼ -10.6% vs 2024
Equity€171.79M-€238.76M▲ 39.0%€163.38M▼ 31.6%€156.82M▼ 4.0%€89.18M▼ 43.1% 2021: €171.79M 2022: €238.76M▲ +39.0% vs 2021highest in 5 years 2023: €163.38M▼ -31.6% vs 2022 2024: €156.82M▼ -4.0% vs 2023 2025: €89.18M▼ -43.1% vs 2024lowest in 5 years
Operating result€-23.28M-€88.15M€-19.55M€23.61M€-8.54M 2021: €-23.28Mlowest in 5 years 2022: €88.15M▲ +479% vs 2021highest in 5 years 2023: €-19.55M▼ -122% vs 2022 2024: €23.61M▲ +221% vs 2023 2025: €-8.54M▼ -136% vs 2024
Net result€-25.38M-€66.97M€-5.38M€17.44M€-12.67M 2021: €-25.38Mlowest in 5 years 2022: €66.97M▲ +364% vs 2021highest in 5 years 2023: €-5.38M▼ -108% vs 2022 2024: €17.44M▲ +424% vs 2023 2025: €-12.67M▼ -173% vs 2024
Result per fiscal year
Operating resultNet result
€-50.00M€0€50.00M€100.00MOperating result 2021: €-23.28M€-23.28MNet result 2021: €-25.38M€-25.38MOperating result 2022: €88.15M€88.15MNet result 2022: €66.97M€66.97MOperating result 2023: €-19.55M€-19.55MNet result 2023: €-5.38M€-5.38MOperating result 2024: €23.61M€23.61MNet result 2024: €17.44M€17.44MOperating result 2025: €-8.54M€-8.54MNet result 2025: €-12.67M€-12.67M20212022202320242025€-20M€0€20MOperating result 2023: €-19.55M€-20MNet result 2023: €-5.38M€-5.4MOperating result 2024: €23.61M€24MNet result 2024: €17.44M€17MOperating result 2025: €-8.54M€-8.5MNet result 2025: €-12.67M€-13M202320242025
The operating result turns negative in 2025: a loss of €8.54M after €23.61M in 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €151.61M
Fixed assets €87.75M ▼ 2.4%
Current assets €63.86M ▼ 66.0%
Equity and liabilities €151.61M
Equity €89.18M ▼ 43.1%
Provisions €3.97M ▲ 43.4%
Debt €58.46M ▼ 50.5%
Debt's share of the balance-sheet total falls from 42.5% to 38.6%. Equity and debt are lower.
Key figures and ratios
2025 value · change against 2024
ROE
-14.2%▼
2024 · 11.1%
ROA
-8.4%▼
2024 · 6.3%
Debt ≤ 1 year
€58.28M▼
2024 · €112.57M
Income taxes
€19k▼
2024 · €1.58M
Staff costs
€7.11M▼
2024 · €7.35M
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 81 lines
Balance sheet Code20242025
Assets
Total assets20/58€277.66M€151.61M▼
Fixed assets21/28€89.95M€87.75M▼
Financial fixed assets28€89.95M€87.75M▼
Affiliated companies280/1€89.95M€87.75M▼
Participating interests280€89.95M€87.75M▼
Current assets29/58€187.71M€63.86M▼
Amounts receivable after more than one year29€273k€519k▲
Other amounts receivable291€273k€519k▲
Stocks and contracts in progress3€23.25M€27.83M▲
Stocks30/36€23.25M€27.83M▲
Raw materials and consumables30/31€606k€4.24M▲
Finished goods33-€217k
Goods purchased for resale34€22.64M€23.38M▲
Amounts receivable within one year40/41€54.06M€18.07M▼
Trade receivables40€37.16M€3.42M▼
Other amounts receivable41€16.90M€14.66M▼
Current investments50/53€109.36M€15.90M▼
Other investments51/53€109.36M€15.90M▼
Cash at bank and in hand54/58€769k€1.54M▲
Equity and liabilities
Total equity and liabilities10/49€277.66M€151.61M▼
Equity10/15€156.82M€89.18M▼
Contributions10/11€141.95M€91.98M▼
Capital10€141.95M€91.98M▼
Issued capital100€141.95M€91.98M▼
Reserves13€14.20M€9.20M▼
Non-distributable reserves130/1€14.20M€9.20M▼
Legal reserve130€14.20M€9.20M▼
Other1319€69€69=
Profit (loss) carried forward14€673k€-12.00M▼
Provisions and deferred taxes16€2.77M€3.97M▲
Provisions for liabilities and charges160/5€2.77M€3.97M▲
Pensions and similar obligations160€1.14M€3.96M▲
Other liabilities and charges164/5€1.64M€8k▼
Amounts payable17/49€118.07M€58.46M▼
Amounts payable within one year42/48€112.57M€58.28M▼
Trade debts44€82.70M€54.68M▼
Suppliers440/4€82.70M€54.68M▼
Taxes, remuneration and social security45€5.87M€3.60M▼
Taxes450/3€3.83M€1.84M▼
Remuneration and social security454/9€2.04M€1.76M▼
Other amounts payable47/48€24.00M€1k▼
Accrued charges and deferred income492/3€5.50M€176k▼
Income statement Code20242025
Operating income70/76A€1.47B€1.32B▼
Turnover70€1.47B€1.31B▼
Change in stocks of work in progress, finished goods and contracts in progress71€-813k€402k▲
Other operating income74€5.65M€4.77M▼
Non-recurring operating income76A€1.77M€2.98M▲
Operating charges60/66A€1.45B€1.33B▼
Goods for resale, raw materials and consumables60€1.32B€1.21B▼
Purchases600/8€1.30B€1.21B▼
Change in stocks: decrease (increase)609€20.85M€-4.27M▼
Services and other goods61€119.09M€111.22M▼
Remuneration, social security and pensions62€7.35M€7.11M▼
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4€-3.18M€-76k▲
Provisions for liabilities and charges: additions (uses and reversals)635/8€2.62M€-1.82M▼
Other operating charges640/8€46k€995k▲
Non-recurring operating charges66A€508k€3.23M▲
Operating profit (loss)9901€23.61M€-8.54M▼
Financial income75/76B€5.06M€3.09M▼
Recurring financial income75€5.06M€3.09M▼
Income from financial fixed assets750-€356k
Income from current assets751€1.41M€1.33M▼
Other financial income752/9€3.65M€1.41M▼
Financial charges65/66B€9.64M€7.20M▼
Recurring financial charges65€7.78M€5.00M▼
Debt charges650€214k€10k▼
Other financial charges652/9€7.57M€4.99M▼
Non-recurring financial charges66B€1.86M€2.20M▲
Profit (loss) for the period before taxes9903€19.02M€-12.65M▼
Income taxes67/77€1.58M€19k▼
Taxes670/3€1.58M€22k▼
Tax adjustments and reversals of tax provisions77-€4k
Profit (loss) for the period9904€17.44M€-12.67M▼
Profit (loss) for the period to be appropriated9905€17.44M€-12.67M▼
Appropriation of the result
Profit (loss) to be appropriated9906€24.67M€-12.00M▼
Profit (loss) brought forward from the previous period14P€7.23M€673k▼
Transfer from equity791/2-€5.00M
From reserves792-€5.00M
Profit to be distributed694/7€24.00M€5.00M▼
Return on contributions (dividend)694€24.00M€5.00M▼
Social balance
Average headcount (FTE)908742.341.9▼

The notes to these accounts (54 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Accounts by statement
Line20212022202320242025Change
Operating income70/76A€1.11B€1.72B€1.47B€1.47B€1.32B▼ 10.5%
Turnover70€1.11B€1.70B€1.47B€1.47B€1.31B▼ 10.6%
Change in stocks of work in progress, finished goods and contracts in progress71€-78k€2.82M€-1.89M€-813k€402k▲ 149%
Other operating income74€2.52M€17.65M€2.02M€5.65M€4.77M▼ 15.5%
Non-recurring operating income76A€279k€317k€67k€1.77M€2.98M▲ 68.4%
Operating charges60/66A€1.13B€1.63B€1.49B€1.45B€1.33B▼ 8.4%
Goods for resale, raw materials and consumables60€1.03B€1.48B€1.36B€1.32B€1.21B▼ 8.8%
Purchases600/8€1.02B€1.49B€1.39B€1.30B€1.21B▼ 7.0%
Change in stocks: decrease (increase)609€2.49M€-8.50M€-28.62M€20.85M€-4.27M▼ 121%
Services and other goods61€96.37M€131.28M€103.47M€119.09M€111.22M▼ 6.6%
Remuneration, social security and pensions62€8.39M€6.77M€6.79M€7.35M€7.11M▼ 3.2%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€9k€4k----
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4€-2.22M€-343€3.08M€-3.18M€-76k▲ 97.6%
Provisions for liabilities and charges: additions (uses and reversals)635/8€112k€-3.23M€-54k€2.62M€-1.82M▼ 169%
Other operating charges640/8€3.31M€13.16M€8.78M€46k€995k▲ 2,082%
Non-recurring operating charges66A€618k€122k€827k€508k€3.23M▲ 534%
Operating profit (loss)9901€-23.28M€88.15M€-19.55M€23.61M€-8.54M▼ 136%
Financial income75/76B€1.97M€3.18M€18.09M€5.06M€3.09M▼ 38.9%
Recurring financial income75€1.97M€3.18M€17.79M€5.06M€3.09M▼ 38.9%
Income from financial fixed assets750€48k€96k€14.38M-€356k-
Income from current assets751€22€67k€209k€1.41M€1.33M▼ 6.2%
Other financial income752/9€1.92M€3.02M€3.20M€3.65M€1.41M▼ 61.3%
Non-recurring financial income76B€212-€303k---
Financial charges65/66B€2.67M€10.90M€4.51M€9.64M€7.20M▼ 25.3%
Recurring financial charges65€2.67M€10.90M€4.51M€7.78M€5.00M▼ 35.7%
Debt charges650€40k€42k€1.34M€214k€10k▼ 95.3%
Write-downs on current assets other than stocks, contracts in progress and trade receivables: additions (reversals)651-€1k----
Other financial charges652/9€2.64M€10.85M€3.17M€7.57M€4.99M▼ 34.0%
Non-recurring financial charges66B--€3k€1.86M€2.20M▲ 18.2%
Profit (loss) for the period before taxes9903€-23.98M€80.44M€-5.97M€19.02M€-12.65M▼ 167%
Income taxes67/77€1.40M€13.47M€-593k€1.58M€19k▼ 98.8%
Taxes670/3€1.40M€14.57M€54k€1.58M€22k▼ 98.6%
Tax adjustments and reversals of tax provisions77-€1.10M€648k-€4k-
Profit (loss) for the period9904€-25.38M€66.97M€-5.38M€17.44M€-12.67M▼ 173%
Profit (loss) for the period to be appropriated9905€-25.38M€66.97M€-5.38M€17.44M€-12.67M▼ 173%
Line20212022202320242025Change
Assets
Total assets20/58€243.88M€346.53M€312.08M€277.66M€151.61M▼ 45.4%
Fixed assets21/28€215.22M€215.21M€140.11M€89.95M€87.75M▼ 2.4%
Intangible fixed assets21€2k-----
Tangible fixed assets22/27€2k-----
Plant, machinery and equipment23€2k-----
Financial fixed assets28€215.21M€215.21M€140.11M€89.95M€87.75M▼ 2.4%
Affiliated companies280/1€215.21M€215.21M€140.11M€89.95M€87.75M▼ 2.4%
Participating interests280€215.21M€215.21M€140.11M€89.95M€87.75M▼ 2.4%
Current assets29/58€28.66M€131.32M€171.97M€187.71M€63.86M▼ 66.0%
Amounts receivable after more than one year29-€5k€45k€273k€519k▲ 90.1%
Other amounts receivable291-€5k€45k€273k€519k▲ 90.1%
Stocks and contracts in progress3€8.80M€20.13M€41.75M€23.25M€27.83M▲ 19.7%
Stocks30/36€8.80M€20.13M€41.75M€23.25M€27.83M▲ 19.7%
Raw materials and consumables30/31€10k€4.43M€6.13M€606k€4.24M▲ 599%
Finished goods33€87k€2.91M€412k-€217k-
Goods purchased for resale34€8.70M€12.79M€35.21M€22.64M€23.38M▲ 3.3%
Amounts receivable within one year40/41€19.86M€111.18M€43.85M€54.06M€18.07M▼ 66.6%
Trade receivables40€9.84M€83.83M€31.34M€37.16M€3.42M▼ 90.8%
Other amounts receivable41€10.02M€27.35M€12.51M€16.90M€14.66M▼ 13.3%
Current investments50/53--€86.17M€109.36M€15.90M▼ 85.5%
Other investments51/53--€86.17M€109.36M€15.90M▼ 85.5%
Cash at bank and in hand54/58--€153k€769k€1.54M▲ 99.5%
Deferred charges and accrued income490/1€661€2k€2k---
Equity and liabilities
Total equity and liabilities10/49€243.88M€346.53M€312.08M€277.66M€151.61M▼ 45.4%
Equity10/15€171.79M€238.76M€163.38M€156.82M€89.18M▼ 43.1%
Contributions10/11€141.95M€141.95M€141.95M€141.95M€91.98M▼ 35.2%
Capital10€141.95M€141.95M€141.95M€141.95M€91.98M▼ 35.2%
Issued capital100€141.95M€141.95M€141.95M€141.95M€91.98M▼ 35.2%
Reserves13€14.20M€14.20M€14.20M€14.20M€9.20M▼ 35.2%
Non-distributable reserves130/1€14.20M€14.20M€14.20M€14.20M€9.20M▼ 35.2%
Legal reserve130€14.20M€14.20M€14.20M€14.20M€9.20M▼ 35.2%
Other1319€69€69€69€69€69=
Profit (loss) carried forward14€15.64M€82.61M€7.23M€673k€-12.00M▼ 1,882%
Provisions and deferred taxes16€4.85M€2.42M€1.86M€2.77M€3.97M▲ 43.4%
Provisions for liabilities and charges160/5€4.85M€2.42M€1.86M€2.77M€3.97M▲ 43.4%
Pensions and similar obligations160€2.74M€2.35M€1.85M€1.14M€3.96M▲ 249%
Other liabilities and charges164/5€2.11M€75k€11k€1.64M€8k▼ 99.5%
Amounts payable17/49€67.24M€105.35M€146.84M€118.07M€58.46M▼ 50.5%
Amounts payable within one year42/48€67.23M€99.44M€146.83M€112.57M€58.28M▼ 48.2%
Financial debts43€23.73M€8.97M----
Other loans439€23.73M€8.97M----
Trade debts44€39.42M€82.68M€72.53M€82.70M€54.68M▼ 33.9%
Suppliers440/4€39.42M€82.68M€72.53M€82.70M€54.68M▼ 33.9%
Taxes, remuneration and social security45€4.07M€7.79M€4.30M€5.87M€3.60M▼ 38.7%
Taxes450/3€2.27M€5.67M€2.40M€3.83M€1.84M▼ 52.0%
Remuneration and social security454/9€1.80M€2.12M€1.91M€2.04M€1.76M▼ 13.9%
Other amounts payable47/48€519-€70.00M€24.00M€1k▼ 100.0%
Accrued charges and deferred income492/3€7k€5.90M€4k€5.50M€176k▼ 96.8%
Line20212022202320242025Change
Profit (loss) for the period9904€-25.38M€66.97M€-5.38M€17.44M€-12.67M▼ 173%
+ Depreciation and write-downs630€9k€4k----
Operating cash flow (approximation)€-25.37M€66.97M€-5.38M€17.44M€-12.67M▼ 173%
Investment in fixed assets (approximation)-€-1k€75.10M€50.16M€2.20M▼ 95.6%
Change in cash---€617k€766k▲ 24.2%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Sign in to download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
25-08
State Gazette act Reappointments: Etienne Galan, Marco Gianuzzi and Céline Van Vlaenderen
Mandate compensation7 facts ▸
  • General meeting, 10-06-2026
  • Director reappointment, Etienne Galan (director)
  • Director reappointment, Marco Gianuzzi (managing director)
  • Director reappointment, Céline Van Vlaenderen (managing director)
  • Mandate compensation, Etienne Galan
  • Mandate compensation, Marco Gianuzzi
  • Mandate compensation, Céline Van Vlaenderen
10-06
NBB filing Annual accounts filed
fiscal year 2025 · full schema
2025
12-08
State Gazette act Reappointment: Ernst & Young Réviseurs d'Entreprises SRL (statutory auditor)
Power of attorney · Auditor representative8 facts ▸
  • Board meeting, 22-04-2025
  • General meeting, 11-06-2025
  • Auditor reappointment, Ernst & Young Réviseurs d'Entreprises SRL
  • Power of attorney, Emmanuël Vandevelde
  • Power of attorney, Xavier Klein
  • Power of attorney, Emmanuël Vandevelde
  • Power of attorney, Xavier Klein
  • Auditor representative, Eric Van Hoof
19-06
NBB filing Annual accounts filed
fiscal year 2024 · full schema
2024
31-12
Financial Back to profitnet €17.44M
Net result €17.44M after one loss-making year.
04-10
State Gazette act Resignation: Frederik Degraeve (director)
Appointment: Céline Van Vlaenderen (director) · Mandate compensation8 facts ▸
  • Board meeting, 25-04-2024
  • Director resignation, Frederik Degraeve (director)
  • Director appointment, Céline Van Vlaenderen (director)
  • Director appointment, Céline Van Vlaenderen (day-to-day manager)
  • Mandate compensation, Céline Van Vlaenderen
  • General meeting, 12-06-2024
  • Director resignation, Frederik Degraeve (managing director)
  • Director appointment, Céline Van Vlaenderen (director)
26-09
State Gazette act Permanent representative: Eric Van Hoof
2 facts ▸
  • Board meeting, 18-07-2024
  • Permanent representative, Eric Van Hoof (permanent representative)
27-06
NBB filing Annual accounts filed
fiscal year 2023 · full schema
18-01
State Gazette act Resignation: Guillaume Bucco (director)
Appointment: Tahsin Alpan Fulat (director) · Director discharge · Mandate compensation6 facts ▸
  • General meeting, 21-11-2023
  • Director resignation, Guillaume Bucco (director)
  • Director discharge, Guillaume Bucco
  • General meeting, 11-12-2023
  • Director appointment, Tahsin Alpan Fulat (director)
  • Mandate compensation, Tahsin Alpan Fulat
2023
19-06
State Gazette act Statutes amendment
Capital3 facts ▸
  • General meeting, 17/05/2023
  • Statutes amendment
  • Capital, €141.951.409
19-06
NBB filing Annual accounts filed
fiscal year 2022 · full schema
2022
31-12
Financial Back to profitnet €66.97M
Net result €66.97M after one loss-making year.
Show earlier events
31-12
Financial Liquidity triplescurrent ratio 1.32
Current ratio from 0.43 to 1.32.
07-10
State Gazette act Resignation: Charles Geuens (director)
Appointments: Marco Giannuzzi, Etienne Galan and 2 others · Permanent representative: Marie Kaisin · Auditor removal13 facts ▸
  • General meeting, 25-05-2022
  • Director resignation, Charles Geuens (director)
  • Director appointment, Marco Giannuzzi (director)
  • Director appointment, Etienne Galan (director)
  • Director appointment, Frederik Degraeve (director)
  • Auditor removal, commissaire, 25-05-2022
  • Auditor appointment, Ernst & Young Réviseurs d'Entreprises SRL (statutory auditor)
  • Permanent representative, Marie Kaisin
  • Board meeting, 25-05-2022
  • Director appointment, Marco Giannuzzi (managing director)
  • Director appointment, Frederik Degraeve (managing director)
  • Mandate compensation, Marco Giannuzzi
  • +1 further facts in this act
23-06
NBB filing Annual accounts filed
fiscal year 2021 · full schema
2021
31-12
Financial Weakest financial yearnet €-25.38M
Net result drops to €-25.38M, the lowest in the series; recovery starts the following year.
06-10
State Gazette act Resignation: Luc Lebrun (director)
Director discharge3 facts ▸
  • General meeting, 30-07-2021
  • Director resignation, Luc Lebrun (director)
  • Director discharge, Luc Lebrun (director)
10-06
NBB filing Annual accounts filed
fiscal year 2020 · full schema
09-06
State Gazette act Reappointments: Luc Lebrun, Charles Geuens and 2 others
Permanent representative: Michel Denayer · Appointment: Charles Geuens (day-to-day manager) · Mandate compensation15 facts ▸
  • General meeting, 10-06-2020
  • Director reappointment, Luc Lebrun (director)
  • Director reappointment, Charles Geuens (director)
  • Director reappointment, Guillaume Bucco (director)
  • Mandate compensation, Luc Lebrun
  • Mandate compensation, Charles Geuens
  • Mandate compensation, Guillaume Bucco
  • Auditor reappointment, Deloitte
  • Permanent representative, Michel Denayer
  • Board meeting, 22-07-2020
  • Director reappointment, Charles Geuens (managing director)
  • Director appointment, Charles Geuens (day-to-day manager)
  • +3 further facts in this act
2020
22-06
NBB filing Annual accounts filed
fiscal year 2019 · full schema
2019
12-07
State Gazette act Capital & shares · Statutes amendment
Capital decrease · Capital · Reserve release7 facts ▸
  • General meeting, 28-06-2019
  • Capital decrease, €445.067,62
  • Capital decrease, €67.650.955,28
  • Capital, €141.951.409
  • Reserve release, prime d'émission, 0 EUR
  • Reserve release, réserve légale, 14.200.000 EUR
  • Power of attorney, Deux administrateurs de la société
17-06
NBB filing Annual accounts filed
fiscal year 2018 · full schema
2018
25-06
NBB filing Annual accounts filed
fiscal year 2017 · full schema
2017
06-07
State Gazette act Reappointment: Deloitte (statutory auditor)
Appointment: Michel Denayer (permanent representative) · Resignation: Eric Nys (permanent representative)4 facts ▸
  • General meeting, 14-06-2017
  • Auditor reappointment, Deloitte
  • Director appointment, Michel Denayer (permanent representative)
  • Director resignation, Eric Nys (permanent representative)
05-07
NBB filing Annual accounts filed
fiscal year 2016 · full schema
2015
13-04
State Gazette act Reappointment: Deloitte (statutory auditor)
2 facts ▸
  • General meeting, 12-06-2014
  • Auditor reappointment, Deloitte
2014
23-07
State Gazette act Resignations: Haimo Zekoll (director) and Harold de Laveleye (director)
Appointment: Charles Geuens (director) · Reappointments: Luc Lebrun (director) and Guillaume Buco (director) · Power of attorney14 facts ▸
  • General meeting, 12-06-2014
  • Director resignation, Haimo Zekoll (director)
  • Director resignation, Harold de Laveleye (director)
  • Director appointment, Charles Geuens (director)
  • Director reappointment, Luc Lebrun (director)
  • Director reappointment, Guillaume Buco (director)
  • Board meeting, 12-06-2014
  • Director appointment, Charles Geuens (managing director)
  • Power of attorney, Charles Geuens
  • Mandate compensation, Charles Geuens
  • Board composition, Le mandat laissé vacant par de Laveleye n'est pas pourvu; le conseil d'administration passe de quatre à trois mandats
  • Mandate compensation, Luc Lebrun
  • +2 further facts in this act
2013
13-05
State Gazette act Resignations & appointments
Power of attorney2 facts ▸
  • Board meeting, 25-04-2013
  • Power of attorney, Alain Dommisse
03-04
State Gazette act Resignation: Jérôme Soudan (director)
Appointment: Haimo Zekoll (director) · Mandate compensation8 facts ▸
  • General meeting, 08-03-2013
  • Director resignation, Jérôme Soudan (director)
  • Director appointment, Haimo Zekoll (director)
  • Mandate compensation, Haimo Zekoll
  • Board meeting, 08-03-2013
  • Director appointment, Haimo Zekoll (managing director)
  • Director appointment, Haimo Zekoll (day-to-day manager)
  • Mandate compensation, Haimo Zekoll
2012
18-07
State Gazette act Miscellaneous
Registered-office move2 facts ▸
  • General meeting, 25-06-2012
  • Registered-office move, 1120 Bruxelles, rue de Ransbeek, 310
02-02
State Gazette act Registered office
Registered-office move2 facts ▸
  • Board meeting, 19-01-2012
  • Registered-office move, rue de Ransbeek 310 à 1120 Bruxelles
2011
19-10
State Gazette act Reappointment: Deloitte (statutory auditor)
Appointment: Guillaume Bucco (chair of the board) · Auditor representative5 facts ▸
  • General meeting, 08-06-2011
  • Auditor reappointment, Deloitte
  • Board meeting, 28-09-2011
  • Director appointment, Guillaume Bucco (chair of the board)
  • Auditor representative, Eric Nys
05-07
State Gazette act Resignations: Etienne Moncombe (director) and Christiane Malcorps (director)
Appointments: Guillaume Bucco (director) and Harold de Laveleye (director) · Mandate compensation · Mandate term9 facts ▸
  • General meeting, 08-06-2011
  • Director resignation, Etienne Moncombe (director)
  • Director resignation, Christiane Malcorps (director)
  • Director appointment, Guillaume Bucco (director)
  • Director appointment, Harold de Laveleye (director)
  • Mandate compensation, Guillaume Bucco
  • Mandate compensation, Harold de Laveleye
  • Mandate term, 2014
  • Mandate term, 2014
2009
16-03
State Gazette act Appointment: Christiane Malcorps (director)
Resignation: Ludwig Decoster (director) · Mandate compensation7 facts ▸
  • General meeting, 19-02-2009
  • Director appointment, Christiane Malcorps (director)
  • Director resignation, Ludwig Decoster (director)
  • Mandate compensation, Christiane Malcorps
  • Board meeting, 20-02-2009
  • Director appointment, Christiane Malcorps (chair of the board)
  • Director resignation, Ludwig Decoster (chair of the board)
2007
05-10
State Gazette act Appointments: Jérôme Soudan (director) and Etienne Moncomble (director)
Resignations: Filipe Constant (director) and Emiel Mes (director) · Mandate compensation · Power of attorney16 facts ▸
  • General meeting, 04-09-2007
  • Director appointment, Jérôme Soudan (director)
  • Director resignation, Filipe Constant (director)
  • Director appointment, Etienne Moncomble (director)
  • Director resignation, Emiel Mes (director)
  • Mandate compensation, Jérôme Soudan
  • Mandate compensation, Etienne Moncomble
  • Board meeting, 04-09-2007
  • Director appointment, Jérôme Soudan (managing director)
  • Director appointment, Etienne Moncomble (managing director)
  • Power of attorney, Jérôme Soudan
  • Power of attorney, Etienne Moncomble
  • +4 further facts in this act
2005
03-10
State Gazette act Appointment: Filipe Constant (director)
Resignation: Gérard Nahon (director) · Mandate compensation · Power of attorney8 facts ▸
  • General meeting, 16-09-2005
  • Director appointment, Filipe Constant (director)
  • Director resignation, Gérard Nahon (director)
  • Mandate compensation, Filipe Constant
  • Board meeting, 16-09-2005
  • Director appointment, Filipe Constant (managing director)
  • Power of attorney, Filipe Constant
  • Mandate compensation, Filipe Constant
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
22 of 23 acts read
About the unread acts

Of the 23 Belgian State Gazette acts we know for this company, 22 have been read. The other one has not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
9 directors, last change in 2024
Céline Van Vlaenderen
Director · since 01-05-2024
Current
Tahsin Alpan Fulat
Director · since 11-12-2023
Current
Etienne Galan
Director · since 31-05-2022
Current
Marco Giannuzzi
Director · since 31-05-2022
Current
Luc Lebrun
Director · since 12-06-2014
Current
Marco Gianuzzi
Managing director
Current
3 other directors
Michel Denayer
Permanent representative · since 14-06-2017
Not recently confirmed
Guillaume Buco
Director · since 12-06-2014
Not recently confirmed
Etienne Moncomble
Director · since 01-10-2007
Not recently confirmed
01-05-2024 Céline Van Vlaenderen: Appointed as Director
01-05-2024 Céline Van Vlaenderen: Appointed as Day-to-day manager
01-05-2024 Frederik Degraeve: Resigned as Director
01-05-2024 Frederik Degraeve: Resigned as Managing director
11-12-2023 Tahsin Alpan Fulat: Appointed as Director
Full history in the Timeline (46 changes) →
Not every act has been read: a resignation may be missing here
1 of this company's 23 Belgian State Gazette acts has not been read yet. Appointments and resignations recorded in them are missing above: a director who resigned there may therefore still show here as sitting. The acts are in the Timeline.
Location & real-estate footprint
Registered office, Brussel · 1 establishment unit since 1969
seat establishment The establishment unit on the map
Ground area
1,224 m²
Parcel 21819A0095/03B000, Brussels. Linked by address, not a title deed.
19 companies at this address See who is registered here
1 establishment unit
Solvay Chemicals International
Ransbeekstraat 310, 1120 BrusselNACE 5151003
since 19692.002.735.145
1 parcel
Brussels 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
21819A0095/03B000 Brussels 1,224 m² - -
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Statutory auditor

1 auditor
Ernst et Young Reviseurs d'EntreprisesCurrent
Auditor
25-05-2022 → present
Show 1 earlier auditors
Deloitte
Auditor · represented by Michel Denayer
succeeded by Ernst et Young Reviseurs d'Entreprises in 2022
08-06-2011 → 25-05-2022

Articles of association

Who signs
“Conformément à l'article 18 des statuts, Messieurs Geuens, Bucco et Lebrun ont qualité pour représenter la société en agissant conjointement avec un autre administrateur.”
Purpose
Toutes opérations financières et plus spécialement l'achat, l'échange, la vente et la gestion de toutes valeurs mobilières, actions, parts sociales et obligations, la prise de…
Full purpose

Toutes opérations financières et plus spécialement l'achat, l'échange, la vente et la gestion de toutes valeurs mobilières, actions, parts sociales et obligations, la prise de participations... l'achat, la vente, la représentation, l'importation, l'exportation et le commerce en général de tous produits chimiques en ce compris les matières plastiques et synthétiques ainsi que de tous les articles comprenant ces matières.

Structure & network

Connections & network

8 connected companies

Ownership & control

1 parent company · 1 subsidiary
Control over this companyparent company per the LEI register1
Brussels
controls
SOLVAY CHEMICALS INTERNATIONALBE 0406.804.736
controls
Where this company holds controlsubsidiary per the LEI register1

Capital and shareholders

Capital over the years
  1. 19-06-2023 Capital stated in the act · 141,951,409 EUR · 338,786,179 shares
  2. 12-07-2019 Capital reduction of 445,067.62 EUR · to 209,602,364.28 EUR · to absorb losses
  3. 12-07-2019 Capital reduction of 67,650,955.28 EUR · to 141,951,409 EUR · repaid to the shareholders

Recognitions · licences · registrations

Food safety, FASFC

1 site
Brussel2.002.735.145
2 permissions
Groothandelaar grondstoffen · since 01-01-2015
Trader · since 01-01-2015

Legal Entity Identifier

549300HNS7FMVARBWZ51
live in the LEI register

Similar companies · same sector, comparable size

Of 24,727 companies in sector 64210 we hold annual accounts for 19,768. 1,946 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Identification & contact

Identification
Legal formPublic limited company
Founded07-08-1969
Fiscal year end31-12
Activities, NACEBEL 2025
46851Wholesale of industrial chemicals
64210Activities of holding companies

Scores and ratios are computed by Checked and are not a credit decision.